These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 31229923
21. Successful use of danaparoid in two pregnant women with heart valve prosthesis and heparin-induced thrombocytopenia Type II (HIT). Gerhardt A, Scharf RE, Zotz RB. Clin Appl Thromb Hemost; 2009; 15(4):461-4. PubMed ID: 18840630 [Abstract] [Full Text] [Related]
22. [Thrombosis of a cardiopulmonary bypass circuit despite recommended hypocoagulation with danaparoid during the acute phase of type II heparin-induced thrombocytopenia]. Salmi L, Elalamy I, Leroy-Matheron C, Houel R, Thébert D, Duvaldestin P. Ann Fr Anesth Reanim; 2006; 25(11-12):1144-8. PubMed ID: 17174213 [Abstract] [Full Text] [Related]
23. Lepirudin use in a neonate with heparin-induced thrombocytopenia. Nguyen TN, Gal P, Ransom JL, Carlos R. Ann Pharmacother; 2003 Feb; 37(2):229-33. PubMed ID: 12549954 [Abstract] [Full Text] [Related]
24. Heparin-induced thrombocytopenia (HIT). A report of 1,478 clinical outcomes of patients treated with danaparoid (Orgaran) from 1982 to mid-2004. Magnani HN, Gallus A. Thromb Haemost; 2006 Jun; 95(6):967-81. PubMed ID: 16732376 [Abstract] [Full Text] [Related]
25. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia]. Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734 [No Abstract] [Full Text] [Related]
27. Lifesaving citrate anticoagulation to bridge ineffective danaparoid [correction of to bridge to danaparoid] treatment. Dworschak M, Hiesmayr JM, Lassnigg A. Ann Thorac Surg; 2002 May; 73(5):1626-7. PubMed ID: 12022563 [Abstract] [Full Text] [Related]
28. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia. Olin DA, Urdaneta F, Lobato EB. J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115 [No Abstract] [Full Text] [Related]
31. Danaparoid for heparin-induced thrombocytopenia: an analysis of treatment failures. Kodityal S, Manhas AH, Udden M, Rice L. Eur J Haematol; 2003 Aug; 71(2):109-13. PubMed ID: 12890149 [Abstract] [Full Text] [Related]
32. Cross-Reactivity Between Heparin and Danaparoid Antibodies in Cardiac Surgery. Ronchard T, Salaun E, Theron A, Grisoli D, Jaussaud N, Collart F, Habib G, Camoin-Jau L. Ann Thorac Surg; 2017 Jan; 103(1):e9-e10. PubMed ID: 28007287 [Abstract] [Full Text] [Related]
33. Preventing complications in heparin-induced thrombocytopenia. Alternative anticoagulants are improving patient outcomes. Rice L, Nguyen PH, Vann AR. Postgrad Med; 2002 Sep; 112(3):85-9. PubMed ID: 12360660 [Abstract] [Full Text] [Related]